OraSure Technologies, Inc.
OSUR
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwā¦ read more
Healthcare
Medical Instruments & Supplies
39 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$4.05
Price+2.02%
$0.08
1Y
Price
Market Cap
$278.837m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.-41.4%
EBITDA Margin-50.6%
Net Profit Margin-40.6%
Free Cash Flow Margin-41.4%
EBITDA Margin-50.6%
Net Profit Margin-40.6%
Free Cash Flow MarginRevenue
$113.015m
-32.3%
1y CAGR-27.3%
3y CAGR-4.0%
5y CAGREarnings
-$75.068m
-208.9%
1y CAGR+22.6%
3y CAGR+23.4%
5y CAGREPS
-$1.04
-207.7%
1y CAGR+14.7%
3y CAGR+16.5%
5y CAGRBook Value
$313.324m
$379.169m
Assets$65.845m
Liabilities$40.465m
DebtDebt to Assets
10.7%
-0.3x
Debt to EBITDAFree Cash Flow
-$47.875m
-285.1%
1y CAGR-49.7%
3y CAGR-45.5%
5y CAGRNo items found.
Press Releases
Statements and updates from the company